CABAZITAXEL PLUS PREDNISONE/PREDNISOLONE SIGNIFICANTLY INCREASES OVERALL SURVIVAL COMPARED TO MITOXANTRONE PLUS PREDNISONE/PREDNISOLONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: FINAL RESULTS WITH UPDATED OVERALL SURVIVAL OF A MULTINATIONAL PHASE III TRIAL (TROPIC)

Author
Ozguroglu, M.
Oudard, S. M.
Hansen, S.
De Bono, J. S.
Sartor, A. O.
Gupta, S.
Shen, L.
Machiels, J.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/135401
Collections